Pancreatic Cancer Research

ResearcherKobe UniversityActive in the last 2 years

Yuki Oka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-2120-5194; OpenAlex author ID A5112655697. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2024: 2 papers

Papers 2

  1. Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00535-023-02069-5↗
  2. Treatment and Prognosis for Pancreatic Duct Disruption Associated With Pancreatic Cancer: A Case Series of 15 Patients. Co-author DOI 10.7759/cureus.67482↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoshiyuki Harada · 2 shared papers, 2024 · strength 0.31
  2. Masahiro Tsujimae · 2 shared papers, 2024 · strength 0.31
  3. Atsuhiro Masuda · 2 shared papers, 2024 · strength 0.31
  4. Takashi Kobayashi · 2 shared papers, 2024 · strength 0.31
  5. Hirochika Toyama · 2 shared papers, 2024 · strength 0.31
  6. Takeshi Tanaka · 2 shared papers, 2024 · strength 0.31
  7. Arata Sakai · 2 shared papers, 2024 · strength 0.31
  8. Takumi Fukumoto · 2 shared papers, 2024 · strength 0.31
  9. Masanori Gonda · 2 shared papers, 2024 · strength 0.31
  10. Mika Miki · 2 shared papers, 2024 · strength 0.31
  11. Yuzo Kodama · 2 shared papers, 2024 · strength 0.31
  12. Shigeto Masuda · 1 shared paper, 2024 · strength 0.15
  13. Kohei Yamakawa · 1 shared paper, 2024 · strength 0.15
  14. Shohei Abe · 1 shared paper, 2024 · strength 0.15
  15. Tomoo Itoh · 1 shared paper, 2024 · strength 0.15
  16. Tomonori Matsumoto · 1 shared paper, 2024 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.